Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125649802 | 12564980 | 2 | F | 20160704 | 20160718 | 20160718 | EXP | UG-CIPLA LTD.-2016UG09368 | CIPLA | RHEIN J, MORAWSKI BM, HULLSIEK KH, NABETA HW, KIGGUNDU R, TUGUME L ET AL.,. EFFICACY OF ADJUNCTIVE SERTRALINE FOR THE TREATMENT OF HIV ASSOCIATED CRYPTOCOCCAL MENINGITIS: AN OPEN LABEL DOSE RANGING STUDY. LANCET INFECT DIS. 2016;16:809 TO 818 | 0.00 | Y | 0.00000 | 20160718 | OT | UG | UG |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125649802 | 12564980 | 1 | PS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | UNK, INDUCTION | 77162 | ||||||||||
| 125649802 | 12564980 | 2 | SS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | 200 MG, DAILY, CONSOLIDATON | 77162 | 200 | MG | ||||||||
| 125649802 | 12564980 | 3 | SS | Efavirenz | EFAVIRENZ | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125649802 | 12564980 | 4 | SS | NEVIRAPINE. | NEVIRAPINE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125649802 | 12564980 | 5 | SS | FLUCONAZOLE. | FLUCONAZOLE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125649802 | 12564980 | 6 | SS | AMPHOTERICIN B. | AMPHOTERICIN B | 1 | Unknown | 0.7-1.0 MG/KG PER DAY | U | U | 0 | ||||||||
| 125649802 | 12564980 | 7 | SS | Rifampicin | RIFAMPIN | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125649802 | 12564980 | 1 | Meningitis cryptococcal |
| 125649802 | 12564980 | 3 | Antiretroviral therapy |
| 125649802 | 12564980 | 4 | Antiretroviral therapy |
| 125649802 | 12564980 | 5 | Meningitis cryptococcal |
| 125649802 | 12564980 | 6 | Meningitis cryptococcal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125649802 | 12564980 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125649802 | 12564980 | Meningitis cryptococcal | |
| 125649802 | 12564980 | Treatment noncompliance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |